wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37604531-5C25041D-8EAF-42C4-B685-69EFB5CEA168
Q37604531-5C25041D-8EAF-42C4-B685-69EFB5CEA168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604531-5C25041D-8EAF-42C4-B685-69EFB5CEA168
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.
P2860
Q37604531-5C25041D-8EAF-42C4-B685-69EFB5CEA168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604531-5C25041D-8EAF-42C4-B685-69EFB5CEA168
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5312f99ba40e3ee491fbae88b864e5a63a57f4d
P2860
The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure.